ANI
02 Jun 2023, 18:27 GMT+10
Abu Dhabi [UAE], June 2 (ANI/WAM): AstraZeneca has announced the launch of its revolutionary cancer medication, IMJUDOreg;(tremelimumab) in the UAE.
The launch makes the UAE one of the first countries in the Middle East to receive access to the medication that marks a significant advancement in the treatment of cancer.
Clinical trials have demonstrated the efficacy and tolerability of IMJUDOreg;in combination with various types of cancer, including metastatic non-small cell lung cancer and hepatobiliary cancers. The drug has shown promising results in extending progression-free survival and overall survival rates, empowering patients with better treatment outcomes and a higher quality of life.
AstraZeneca hosted a series of workshops and sessions to introduce the new medications to healthcare experts in the UAE. The sessions saw the participation of over 100 healthcare professionals from major cancer healthcare facilities. During the sessions, several regional and international healthcare experts showcased the revolutionary data of using immunotherapy combinations to improve the survival of liverlung cancer patients who are in urgent need of new effective medications, noting the high unmet needs.
The launch of IMJUDOreg;in the UAE comes in line with the country's growing focus on quality cancer care, with over 30 cancer centres and clinics across the country. Following the directives of the Ministry of Health and Prevention (MoHAP), the UAE has been consistently implementing comprehensive strategies to enhance cancer care, improve early detection, and promote innovative treatments. The launch of IMJUDOreg;cements the UAE's pledge to advancing oncology care and offers patients and families access to cutting-edge therapies.
Additionally, the launch of the innovative medication reflects AstraZeneca's commitment to transforming the landscape of comprehensive cancer care in the UAE and the Middle East. The company is dedicated to improving patient outcomes and family well-being, with IMJUDOreg;as a testament to this mission.
On this occasion, Sameh El Fangary, GCC and Pakistan Cluster President at AstraZeneca stated: "Our mission is to continue to collaborate with our partners to transform health and wellbeing for people, society, and the planet. This collaboration highlights our unwavering commitment to accelerating the latest innovation to the UAE and to the region, inspired by our strategic focus to eliminate cancer-related deaths. We pride ourselves on our successful presence in the UAE spanning over four decades, and our continuous collaboration with MOHAP that allows us to collectively provide the UAE with the latest and most innovative medical solutions."Dr. Humaid Al Shamsi, Head of the Emirates Oncology Society added: "IMJUDOreg;represents an important step in our global fight against several types of cancer, especially that the primary data supporting this revolutionary medication indicates that it is the first and only approved therapy in combination with IMFINZIreg;having 3-year data in first-line advanced or unresectable hepatocellular carcinoma. This breakthrough immunotherapy drug offers new hope for patients and their families. It also reinforces the UAE's position as a leader in cancer care in the Middle East and a global destination for healthcare. We look forward to seeing the positive impact of IMJUDOreg;on patient outcomes and continuing our collaboration with AstraZeneca in the fight against cancer."AstraZeneca remains committed to ensuring the availability and accessibility of IMJUDOreg;in the UAE, as the company is continuing to collaborate with healthcare providers, policymakers, and patient advocacy groups to raise awareness about IMJUDOreg;and its role in transforming cancer care. (ANI/WAM)
Get a daily dose of Iran Herald news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Iran Herald.
More InformationLONDON, UK: In August, global production of primary aluminum hit an all-time high, with production running at an annualized rate ...
NEW YORK, New York - Easing pressure on U.S. Treasury yields boost stocks on American markets Thursday. Gains however were ...
DEARBORN, Michigan: Due to concerns about its ability to operate competitively while it is locked in broader union contract negotiations, ...
OTTAWA, Canada: As part of its plan to capitalize on strong travel demand and deploy fuel-efficient airplanes, this week, Air ...
LONDON, UK: This week, Adidas' newest running shoes, the Adizero Adios Pro Evo 1, went on sale for US$500. Worn ...
NEW YORK, New York - U.S. stocks remained on a slippery slope on Wednesday as interest rates continued to hover ...
ISLAMABAD, Pakistan - Caretaker Foreign Minister Jalil Abbas Jilani stated on Saturday that Pakistan's decision to establish relations with Israel ...
BRASILIA, 29th September, 2023 (WAM) -- The UAE Embassy in Brazil organised a sports event entitled "Arab Emirates COP28 RUN", ...
Hangzhou [China], September 29 (ANI): Indian football head coach Igor Stimac lauded the men's senior side for their performance at ...
Washington DC [US], September 29 (ANI): External Affairs Minister S Jaishankar and his US counterpart Antony Blinken held discussions on ...
ABU DHABI, 28th September, 2023 (WAM) -- President His Highness Sheikh Mohamed bin Zayed Al Nahyan conducted a phone call ...
FUJAIRAH, 28th September, 2023 (WAM) -- H.H. Sheikh Mohammed bin Hamad bin Mohammed Al Sharqi, Crown Prince of Fujairah, received ...